MFS
RPRX icon

Mirabella Financial Services’s Royalty Pharma RPRX Stock Holding History

Mirabella Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,452
Closed -$664K – 568
2023
Q3 		$664K Buy
+24,452
New +$726K 0.09% 194
2020
Q4 		– Sell
-95,442
Closed -$4.01M – 461
2020
Q3 		$4.01M Buy
+95,442
New +$4.09M 0.55% 27

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirabella Financial Services's RPRX Position: Q4 2023 in Review

Mirabella Financial Services sold out of Royalty Pharma (RPRX) in Q4 2023, closing a stake of 24,452 shares — an estimated $664K sold.

Mirabella Financial Services first reported a position in RPRX in Q3 2020 and held it in 2 quarters. The position peaked at $4.01M in Q3 2020. 363 funds tracked by Wall St. Rank hold RPRX as of Q4 2023.

  • Mirabella Financial Services reported no remaining Royalty Pharma position as of Q4 2023 after selling out during the quarter.
  • Mirabella Financial Services sold 24,452 Royalty Pharma shares in Q4 2023, an estimated $664K.
  • Mirabella Financial Services first reported a position in Royalty Pharma in Q3 2020 and held it in 2 quarters.
  • Mirabella Financial Services's Royalty Pharma position peaked at $4.01M in Q3 2020.
  • 363 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2023.

Based on Mirabella Financial Services's 13F filing for Q4 2023, filed 14 Feb 2024.